Iuliana Toma-Dasu is a professor of medical physics at the Department of Physics, Stockholm University, and head of the Division of Medical Radiation Physics at Stockholm University, which is also affiliated with the Department of Oncology and Pathology. Toma-Dasu's research focuses on the development of biologically optimized doses and adaptive radiation therapy for various types of radiation and tumor forms. She plays a key role in the establishment of the center.

Iuliana Toma-Dasu , what is the most important challenge in today's radiation therapy that you want to help solve?
- More than half of all cancer patients need radiotherapy at some point. Yet patients with the same cancer often receive similar treatments, even though their tumours and healthy tissues can respond differently. We want to understand and predict why some tumours resist radiation and why some patients develop more side effects. This could help us choose the most effective treatment for each person, curing more patients while causing as little harm as possible.
How can your research contribute to more personalized treatment for cancer patients?
- We study how radiation affects cancer cells and healthy tissues. We combine detailed medical images with mathematical models based on physics and biology. The images can reveal features that make a tumour harder to treat. Our models use this information to help predict how each patient might respond to radiation. The aim is to tailor treatment to the individual, rather than the average patient.
Why is collaboration between universities, technical experts, and the healthcare sector necessary to develop the radiation therapy of the future?
- Better radiotherapy needs expertise in medicine, physics, biology and technology. As medical physicists, we help connect these fields. Researchers study how radiation affects cancer and healthy tissues, healthcare professionals bring knowledge of patients' needs, and engineers develop new technology. By working together, we can turn discoveries into better treatments.
What development in your field of research are you most looking forward to over the next ten years?
- I am excited about the possibility of creating a 'digital twin' of each patient. This is a computer model that combines information about their tumour, body and how they respond to radiation. It could let us compare treatments on a computer before choosing the one most likely to work for that person.
Together with better medical images and artificial intelligence, these models could help us tailor treatment from the start and adjust it as the patient responds.
What benefits will patients experience in the future if the center succeeds in its ambitions?
- I hope patients will receive more effective, precise treatments that are gentler on their bodies. This could mean better chances of a cure, fewer side effects, shorter treatments and fewer health problems later in life. We want each patient to receive treatment suited to their needs and based on the latest research. Our goal is to help people not only survive cancer, but live well afterwards, benefiting society too.
Why is the Centre of medical radiation science important?
- Bringing discoveries to patients sooner. Helping researchers develop, test and introduce new ideas and technologies into everyday care more quickly.
- Tailoring radiotherapy to each patient. Combining physics, biology, medicine and technology to adapt treatment to each person and their cancer.
- Training the next generation and connecting research with healthcare. Bringing researchers, healthcare professionals, engineers and students together to share knowledge, develop ideas and build skills for future radiotherapy.